Healthcare -
Biotechnology - NASDAQ - US
$ 5.44
2.84 %
$ 350 M
Market Cap
-5.49
P/E
CRVS - NET CHANGE IN CASH
Net Change in Cash CRVS - Corvus Pharmaceuticals, Inc.
-539 K
LAST VALUE
-0.57%
2 YEAR CAGR
38.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR